Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.06.652359

The effects of E. granulosus PSCs proteins on host immune cells were elucidated through Transcriptomic and Metabolomic analyses

Abstract

BackgroundEchinococcus granulosus (E. granulosus), a causative agent of zoonotic diseases, is widely prevalent across most regions and primarily affects vital organs such as the liver and lungs. The parasite secretes immunomodulatory substances, and its protoscolex proteins (PSCs) have been identified as potential diagnostic antigens and vaccine candidates. Although transcriptomics and metabolomics approaches have been employed to investigate echinococcosis, the impact of PSCs on the functionality of host immune cells and the expression of immunomodulatory-related genes remains largely unexplored. MethodsIn this study, immunofluorescence analysis was employed to determine the binding of PSCs to lymphocytes. The CCK-8 assay was utilized to evaluate the impact of varying concentrations of PSCs on cell viability, while ELISA was performed to quantify the levels of cytokines such as IL-9 and IL-4. Furthermore, by integrating LC-MS/MS-based metabolomics and RNA-Seq-based transcriptomics technologies, a systematic analysis was conducted to investigate the metabolic reprogramming and differential gene expression in lymphocytes following PSCs treatment, thereby elucidating the molecular mechanisms underlying its immune regulatory effects. ResultsPSCs proteins inhibited lymphocyte proliferation in a concentration-dependent manner, promoted IL-9 secretion at low concentrations, enhanced IL-4 expression at medium concentrations, and continuously up-regulated TGF-{beta} with increasing concentrations. Transcriptomic analysis identified 1,840 differentially expressed genes (991 up-regulated and 849 down-regulated), and KEGG enrichment analysis highlighted metabolic pathways, including phenylalanine metabolism. Gene Ontology (GO) analysis revealed that the functions of these genes were primarily associated with immunometabolic reprogramming and regulation of the intestinal barrier. Metabonomic profiling detected 12 significantly altered metabolites (8 up-regulated and 4 down-regulated). These findings suggest that PSCs reshape the host immune microenvironment via a metabolic-gene network. This study systematically elucidates how PSCs regulate immune cell function and metabolic homeostasis through multiple targets, providing novel insights into the immune escape mechanisms of parasites. ConclusionPSCs can induce host immune metabolic reprogramming, characterized by the activation of pyrimidine metabolism and the inhibition of bilirubin-mediated oxidative stress, through concentration-dependent regulation of Th9 cytokines (IL-9, IL-4/TGF-{beta}) and suppression of the PI3K-Akt signaling pathway. This process remodels the immune tolerance microenvironment. The aim is to elucidate the molecular mechanisms underlying parasite escape via multi-dimensional immunometabolic regulation, thereby providing a novel direction for the targeted treatment of echinococcosis. Author summaryE. granulosus is a zoonotic disease that can cause space-occupying lesions in the liver, lung and other organs, seriously threaten human health and cause economic losses in animal husbandry. It evades immune attack through a variety of mechanisms.This study investigates the regulatory effects of E. granulosus PSCs on host immune cell function, with a focus on their concentration-dependent influence on Th9 cell differentiation and cytokine expression, including IL-9. Through integrative analyses of transcriptomics and metabolomics, we elucidate the molecular mechanisms underlying immunometabolic reprogramming induced by PSCs. Our findings demonstrate that at low concentrations, PSCs promote the secretion of IL-9 associated with Th9 cells, upregulate IL-4/TGF-{beta} signaling, activate pyrimidine metabolism (leading to thymidine accumulation), enhance bile secretion pathways, and increase bilirubin levels to suppress oxidative stress and T-cell function, thereby establishing an immune-tolerant microenvironment. This research provides the first comprehensive illustration of immune microenvironment remodeling mediated by PSCs via multi-omics network regulation, offering novel insights into the treatment of cystic echinococcosis and host-parasite interactions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Aimulajiang, K., Chen, X., Aizezi, M., Zhou, T., Lin, R., Wen, H.. 2025-05-10. The effects of E. granulosus PSCs proteins on host immune cells were elucidated through Transcriptomic and Metabolomic analyses. https://doi.org/10.1101/2025.05.06.652359

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

TFAM Dependent Mitochondrial Fitness Limits CD8⁺ T Cell Immunopathology and Sustains Protective Immunity during Viral Pneumonia

During respiratory virus infection, CD8 T cells kill infected cells and establish antigen-specific memory, but mechanisms regulating these functions remain incompletely understood. Here, we identify mitochondrial transcription factor A (TFAM)-dependent mitochondrial fitness as a regulator of CD8 T cell function during influenza infection. Human CD8 T cells exhibited an age-associated decline in TFAM expression and mitochondrial function. To model this physiologically relevant decline and determine its consequences for antiviral immunity, we generated CD8 T cell-specific TFAM-haploinsufficient mice. TFAM insufficiency disrupted mitochondrial integrity and bioenergetics and increased mitochondrial DNA and oxidative stress. During influenza infection, TFAM-insufficient CD8 T cells exhibited increased cytotoxic and inflammatory activity associated with lung immunopathology without improved viral control. This early phenotype was followed by loss of effector function, diminished antigen-specific responses, reduced protection following adoptive transfer, and impaired heterosubtypic recall immunity. Thus, TFAM-dependent mitochondrial fitness is a cell-intrinsic regulator that limits immunopathology while sustaining recall immunity.

immunology↗

Gasdermin E couples mitochondrial stress to STING-driven neuronal pyroptosis during Chandipura virus encephalitis

Neurotropic RNA viruses are major causes of fatal encephalitis worldwide, yet how infected neurons transition from antiviral defense to inflammatory cell death is not well characterized. Chandipura virus (CHPV), an emerging neurotropic rhabdovirus, causes acute, rapidly progressive encephalitis with high case fatality in children, but the mechanisms underlying its neuropathogenesis remain poorly defined. Here, we demonstrate that CHPV suppresses canonical RNA virus sensing early but subsequently switches to a mitochondria-driven innate immune program that culminates in inflammatory cell death. Early infection of neuronal cells with CHPV was marked by reduced levels of the mitochondrial antiviral adaptor protein, MAVS and attenuation of type I and III interferon responses. As infection progressed, mitochondrial dysfunction promoted accumulation of mtROS, mitochondrial accumulation of cleaved GSDME and cytosolic mtDNA release, triggering STING activation, which coincided with robust neuroinflammation and pyroptotic cell death. Pharmacological inhibition or genetic silencing of STING markedly attenuated inflammatory signaling, prevented pyroptotic membrane rupture and protected neurons from cell death without significantly affecting viral replication. In contrast, GSDME depletion reduced both viral replication and neuronal death. Notably, GSDME depletion markedly attenuated STING phosphorylation, while STING depletion also reduced GSDME activation, revealing functional coupling between these pathways during CHPV-induced neuronal injury. Collectively, our findings identify a mitochondria-GSDME-STING axis linking early immune evasion to neuroinflammation during CHPV infection, revealing a previously unrecognized mechanism of inflammatory neuronal death in viral encephalitis and highlighting STING as a potential therapeutic target in certain CNS viral infections.

immunology↗

Mutanome-guided immunopeptidomics of blood plasma for neoepitope detection in solid tumors is constrained by cfDNA variant calling sensitivity and MS detection limits

Introduction: Neoepitopes form the basis of tumor-specific immune responses. Tissue biopsy, the primary source for neoepitope detection, is limited and invasive. Therefore, we aimed to identify neoepitopes by mutanome-guided immunopeptidomics from plasma of cancer patients. Methods: Mass spectrometry (MS) data analysis of HLA ligands from plasma (n = 4) was guided by patient-specific mutanomes of cell-free DNA (cfDNA) from plasma or tumor genomic DNA (tgDNA) from tissue. Matched tumor tissue and healthy donor plasma served as controls. Neoepitopes were validated with synthetic peptides, and immunogenicity was assessed using IFN-gamma ELISpot and intracellular cytokine staining. Results: Wild-type immunopeptidomes from tissue and plasma overlapped by 58%, with 91% of plasma HLA ligands rediscovered in tissue. 13 out of 15 tumor-associated HLA ligands detected in plasma were rediscovered in the matching tissue. However, no neoepitopes in plasma were identified by immunopeptidomics guided by cfDNA mutanomes, likely reflecting the limited overlap between cfDNA and tgDNA mutanomes (15%). Using the tgDNA mutanome as a complementary reference, two neoepitopes were detected in one patient's plasma, albeit at the MS detection limit. Both neoepitopes were also discovered in tissue, along with three tissue-exclusive neoepitopes. Two tissue-exclusive neoepitopes induced antigen-specific T cell responses in healthy donor PBMCs. Conclusion: In summary, plasma immunopeptidomics enables profiling of HLA ligands from wild-type proteins, including TAAs. In principle, neoepitope detection from plasma at the peptide level is feasible, but tissue remains the gold standard for variant calling and neoepitope identification. Improved detection methods may enable minimally invasive approaches in the future.

immunology↗